Joseph Brown's questions to Biostem Technologies Inc (BSEM) leadership • Q2 2024
Question
Joseph Brown inquired about the biological source of AmnioWrap, asking if it comes exclusively from placental material and if it could potentially be manufactured artificially in the future.
Answer
Executive Jason Matuszewski confirmed that the company currently uses perinatal tissue as the source material. He explained that the products are regulated as 361 tissue transplant allografts, where the product's function in the donor (a protective barrier) is equivalent to its use in the recipient. He noted that creating the material artificially would require a different, more substantial regulatory pathway (e.g., a BLA or drug development process), but the company is always exploring new opportunities through its R&D and M&A pipelines.